Corpay Soars 10% on Q3 Beat and Raised Outlook, Delivering “57.4% EBITDA Margins”

Corpay (CPAY) shares rose 10% after Q3 earnings beat expectations with $7.54 adjusted EPS and $1.38B revenue. The company raised its 2026 adjusted EPS guidance to $28.00, above analyst estimates of $27.43. Corporate Payments grew 18% organically, outpacing rivals WEX (WEX) and BILL (BILL).

Original reporting
Published Nov 5, 2026, 3:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 4:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Corpay Soars 10% on Q3 Beat and Raised Outlook, Delivering “57.4% EBITDA Margins” — source image
Decision brief

The 30-second read

$CPAYBullishHigh
01

Why it matters

The earnings beat and guidance raise are fresh primary disclosures, offering a clear trading catalyst.

02

Market read

The earnings surprise and outlook lift provide a high‑impact, time‑sensitive trading opportunity.

03

What to watch

Potential competitive pressure from WEX and BILL could moderate long‑term gains.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Corpay (CPAY) announced Q3 results with revenue of $1.38 B, adjusted EPS of $7.54, and a 10% share surge.

Company-level read

Ticker impact

$CPAYBullishHigh confidence
Context

Corpay reported Q3 earnings beat and raised its 2026 EPS outlook, sending the stock up 10% intraday.

Expected impact

likely upward pressure as investors price in higher earnings and margins.

Evidence & confidence

The company delivered $7.54 adjusted EPS vs $7.20 expected and lifted 2026 EPS guidance to $28.00, driving a 10% share jump.

Market effects

Corporate payments segment shows strong growth, potentially benefiting peers in the payments space.

U.S. fintech sector may see modest uplift from Corpay's beat.

Limited to U.S. markets; no immediate global ripple.

Counterpoint

If the raised outlook is already priced in, the stock could face short‑term profit‑taking.

Key entities

  • Corpay

    U.S. fintech firm specializing in corporate payments.

Related articles

$CPAYMed

Corpay Q3 Earnings Call Highlights

Corpay (NYSE:CPAY) expects 9-11% organic revenue growth in 2027, with $2B in free cash flow for acquisitions or share repurchases. The company divested noncore businesses in 2026, using proceeds for buybacks. Alpha and Avid are expected to contribute over $1.40 in combined cash EPS accretion in 2026. Corpay aims to compound adjusted EPS by over 20% annually through 2029.

$CPAYMed

Corpay Inc (CPAY) (Q3 2026) Earnings Call Highlights: Sixth Straight Quarter

Corpay Inc (CPAY) reported Q3 2026 earnings, guiding Q4 organic revenue growth at 10%, slightly below Q3's 11%. Corporate payments growth is ~17% excluding one-time items, while lodging and vehicle payments show mixed results. The company may pursue divestitures and is uncertain about acquiring the remaining stake in Avid. Operating costs rose 9%, and tax rate decreased to 23.4%. CEO Ronald Clarke highlighted strong corporate payments growth and potential for 2027.

$CPAYHighAI 8/10

Corpay’s (NYSE:CPAY) Q3 2026 sales beat estimates

Corpay (NYSE:CPAY) reported Q3 2026 revenue of $1.38 billion, exceeding estimates by 1.7% and growing 17.9% year-on-year. Pre-tax profit was $502.3 million with a 36.3% margin. Adjusted EPS of $7.54 beat estimates by 4.7%. The company raised its full-year revenue guidance to $5.35 billion and adjusted EPS guidance to $28.

$CPAYMedAI 8/10

Corpay earnings beat by $0.35, revenue topped estimates

Corpay (CPAY) reported Q3 EPS of $7.54, beating estimates by $0.35, with revenue at $1.38B, also topping forecasts. The company guided Q4 2026 EPS to $7.65 and revenue to $1.37B, both above consensus. FY 2026 EPS is expected at $27.90-$28.10, with revenue of $5.34B-$5.36B. CPAY's stock is up 6.50% over 3 months and 59.91% over 12 months.